ZiaDerm Research is currently enrolling participants for a belly fat clinical trial in the Miami, Aventura, Broward, and Fort Lauderdale areas. Qualified participants will receive all study-related care from an experienced clinical research team. The study is evaluating an investigational injectable treatment designed to reduce unwanted abdominal subcutaneous fat. The Phase 3 study compares CBL-514 injections with placebo.
To Qualify:
- Must be 18 years of age or older
- Have unwanted or excess belly fat that you would like to reduce
- Have a BMI greater than 18.5 and less than 30
- Weigh at least 110 lbs
- Have maintained a generally stable weight and lifestyle for at least 3 months
- Be willing to travel to our locations and complete all required study visits
- No insurance is needed
- All study-related care is provided at no cost
- Participants may qualify for compensation for their time
The study specifically enrolls adults with protocol-defined Grade 3 or Grade 4 abdominal fat, which is confirmed during the formal study screening.
To learn more, fill out the form on this page or call (786) 589-5183.
NO COST. NO INSURANCE. MAY QUALIFY FOR COMPENSATION.
Participants May Be Compensated for Their Time
- Study participation lasts approximately 28 weeks
- Participants may receive up to 4 abdominal treatment sessions, approximately once every 4 weeks
- The study includes follow-up visits after treatment
The protocol describes up to 12 weeks of treatment followed by 12 weeks of follow-up, with a screening period of up to 28 days.
What Is Abdominal Subcutaneous Fat?
Abdominal subcutaneous fat is the fat located beneath the skin of the stomach or belly area. Even with diet and exercise, some people continue to have unwanted localized belly fat and may be interested in non-surgical options for reducing it.
This clinical trial is evaluating CBL-514, an investigational injectable treatment containing curcumin and trans-resveratrol, for reducing abdominal subcutaneous fat. Participants are randomly assigned to receive either CBL-514 or placebo, and treatment is administered by subcutaneous injections into the abdominal area.
We are seeking adults who are dissatisfied with excess abdominal fat and meet the study’s requirements. If this applies to you, you may qualify for the study.
About ZiaDerm Research
ZiaDerm Research is a clinical research center with more than 20 years of experience conducting dermatology clinical trials. Our experienced research staff and board-certified dermatologists have conducted hundreds of studies for companies including AbbVie, Eli Lilly, Galderma, and Pfizer.
ZiaDerm Research conducts Phase 2 through Phase 4 clinical trials, with participant safety as a top priority. To learn more about this belly fat clinical trial, the time commitment, participant responsibilities, and what to expect, fill out the form or call (786) 589-5183.